Mirum Pharmaceuticals revenue was $307.03M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $90.4M, up 16.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, MIRM annual revenue was $186.4M, with 141.8% growth year-over-year.
MIRM past revenue growth
How has MIRM's revenue growth performed historically?
On Invalid Date, Mirum Pharmaceuticals (NASDAQ: MIRM) reported Q3 2024 revenue of $90.38 million up 89.37% year over year. In the same quarter last year, Mirum Pharmaceuticals's revenue was $47.73 million.
What was Mirum Pharmaceuticals's revenue in 2023?
Mirum Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2023 was $186.37 million, a 141.85% increase year over year.
How much does Mirum Pharmaceuticals make in a day?
Based on Mirum Pharmaceuticals annual revenue for the past four years, MIRM makes an average of $193,543.84 per day.
What was Mirum Pharmaceuticals's annual revenue growth in the past year?
As of Q1 2025, Mirum Pharmaceuticals's revenue has grown 112.14% year over year. This is 1,003.44 percentage points lower than the US Biotechnology industry revenue growth rate of 1,115.58%. Mirum Pharmaceuticals's revenue in the past year totaled $307.03 million.
How much does Mirum Pharmaceuticals make in a year?
Mirum Pharmaceuticals's revenue by year for the past four years is:
Mirum Pharmaceuticals's revenue for the twelve months ending Dec 31, 2023 was $186.37 million, a 141.85% increase year over year.
Mirum Pharmaceuticals's annual revenue for Dec 31, 2022 was $77.06 million, a 302.66% increase from 2021.
Mirum Pharmaceuticals's annual revenue for 2021 was $19.14 million, a Infinity% increase from 2020.
Mirum Pharmaceuticals's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.